Oyster Point Pharma, Inc.

CIK 1720725 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Oyster Point Pharma, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2023SC 13G/A0001104659-23-021891
Feb 14, 2023SC 13G/A0000899140-23-000375
Feb 14, 2023SC 13G/A0000902664-23-001714
Jan 13, 202315-12G0001193125-23-008484
Jan 13, 20238-K/A0001193125-23-008477
Jan 13, 2023SC 13D/A0001193125-23-008356
Jan 9, 2023SC 13D/A0001072613-23-000017
Jan 5, 2023EFFECT9999999995-23-000038
Jan 5, 202340000899243-23-000999
Jan 5, 2023SC 13D/A0001193125-23-002454
Jan 4, 202340001209191-23-001065
Jan 4, 202340001209191-23-001088
Jan 4, 202340001209191-23-001095
Jan 4, 202340001209191-23-001059
Jan 4, 202340000899243-23-000677
Jan 4, 202340001209191-23-001073
Jan 4, 202340001209191-23-001101
Jan 4, 202340001209191-23-001092
Jan 4, 202340001209191-23-001125
Jan 4, 202340001209191-23-001084
Jan 4, 202340001209191-23-001140
Jan 4, 202340001209191-23-001077
Jan 3, 202325-NSE0001354457-23-000001
Jan 3, 2023S-8 POS0001193125-23-000336
Jan 3, 2023POS AM0001193125-23-000327